Glioblastoma Multiforme (GBM) Treatment Market Forecast and Insights: Exploring Growth Trends, Market Size, and Emerging Opportunities
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theGlioblastoma Multiforme (GBM) Treatment Market?
The growth of the Glioblastoma Multiforme (GBM) treatment market is primarily driven by the escalating prevalence of brain disorders. Brain disorders include abnormal brain functionalities and issues with nerves spread across the human body and the spinal cord. Factors such as an aging population, impaired immune systems, overdiagnosis, ionizing radiation, air pollution, and others lead to a rise in brain disorders like GBM, necessitating efficient treatment to enhance wellness. A study by the American Cancer Society, a US-based non-profit committed to cancer eradication, highlighted that approximately 25,050 malignant brain or spinal cord cancer cases were identified in the US in 2022. Consequently, the rising occurrence of brain disorders propels the expansion of the GBM treatment market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8803&type=smp
#What is the Projected CAGR for the Glioblastoma Multiforme (GBM) Treatment Market Size from 2025 to 2034?
The market for the treatment of glioblastoma multiforme (GBM) has experienced rapid expansion in recent years. It is projected to increase from $2.48 billion in 2024 to $2.74 billion in 2025, with a compound annual growth rate (CAGR) of 10.2%. The boost in growth during earlier periods can be accredited to a surge in incident and prevalence rates, progress in diagnostic methods, clinical research and funding, collaborations and alliances, along with a better comprehension of tumor biology.
Predictions indicate a swift expansion in the coming years for the glioblastoma multiforme (GBM) treatment market, with expectations to reach $4.1 billion in 2029, reflecting a compound annual growth rate (CAGR) of 10.6%. This anticipated growth during the forecast period is linked to the advent of immunotherapies, progress in precision medicine, broader understanding of genetic markers, patient advocacy and awareness, and government aid for rare diseases. The forecast period is also likely to see major trends like the investigation of combination therapies, the incorporation of artificial intelligence in diagnosis and treatment planning, an increase in the uptake of immunotherapeutic strategies, and advancements in medical tools and equipment.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8803
What Are the Current Market Growth and Trends in theGlioblastoma Multiforme (GBM) Treatment Market That Industry Players Should Watch?
Leading firms in the market are concentrating on the production of innovative wearable and portable devices to maintain their market prominence. These technological enhancements are designed to provide users with improved functionality, convenience, and comfort, addressing the rising demand for effective and accessible healthcare solutions. For example, Novocure, an oncology firm based in Jersey, introduced a wearable and portable treatment system named Optune Gio in 2023, specifically for patients with newly diagnosed glioblastoma (GBM). This device, which received FDA approval, utilizes Tumor Treating Fields (TTFields), alternating electrical fields that inhibit the division of cancer cells, potentially prolonging the survival of patients. With a weight of just 2.7 pounds, Optune Gio is designed for user comfort, permitting patients to use it during their daily routines.
What Are the Major Market Players Making an Impact on theGlioblastoma Multiforme (GBM) Treatment Market Growth?
Major companies operating in the glioblastoma multiforme (GBM) treatment market include Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, AstraZeneca PLC, Amgen Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, Jazz Pharmaceuticals Inc., Sumitomo Dainippon Pharma Oncology Inc., Varian Medical Systems Inc., Amneal Pharmaceuticals Inc., Elekta AB, ANI Pharmaceuticals Inc., Accord Healthcare Limited, The Eckert & Ziegler Group, Loxo Oncology Inc., Karyopharm Therapeutics Inc., Celon Laboratories Pvt. Ltd., EnGeneIC Ltd., Zydus Pharmaceuticals Inc., Genenta Science S.r.l., Cantex Pharmaceuticals Inc., Vascular Biogenics Ltd., Seelos Therapeutics Inc, Angiochem Inc., Diffusion Pharmaceuticals Inc.
Order Your Report Now For A Swift Delivery:
How Are the Key Segments of the Glioblastoma Multiforme (GBM) Treatment Market Driving Opportunities and Innovations?
The glioblastoma multiforme (GBM) treatment market covered in this report is segmented –
1) By Treatment: Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Tumor Treating Field (TTF) Therapy, Immunotherapy
2) By Drug Class: Temozolomide, Bevacizumab, Lomustine, Carmustine Wafers, Other Drug Classes
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations
4) By End-Use: Hospitals, Clinics, Ambulatory Surgical Centers
Subsegments:
1) By Surgery: Tumor Resection, Biopsy Procedures
2) By Radiation Therapy: External Beam Radiation Therapy (EBRT), Stereotactic Radiation Therapy
3) By Chemotherapy: Standard Chemotherapy, Combination Chemotherapy Regimens
4) By Targeted Therapy: EGFR Inhibitors, Other Targeted Agents
5) By Tumor Treating Field (TTF) Therapy: Device-Based TTF Treatment
6) By Immunotherapy: Checkpoint Inhibitors, Vaccine-Based Therapies
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=8803&type=smp
What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theGlioblastoma Multiforme (GBM) Treatment Market?# Market Expansion?
North America was the largest region in the glioblastoma multiforme (GBM) treatment market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glioblastoma multiforme (gbm) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Glioblastoma Multiforme (GBM) Treatment Market 2025, By The Business Research Company:
Glass Curtain Wall Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/glass-curtain-wall-global-market-report
Industrial Mold Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/industrial-mold-global-market-report
Structural Insulated Panels Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/structural-insulated-panels-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
